Vivo Capital VIII, LLC's Net Worth
$0
Who is Vivo Capital VIII, LLC?
Vivo Capital VIII, LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Crinetics Pharmaceuticals, Inc., Menlo Therapeutics Inc., Aligos Therapeutics, Inc., Terns Pharmaceuticals, Inc., IMPEL PHARMACEUTICALS INC, Bolt Biotherapeutics, Inc., Kadmon Holdings, Inc., Nabriva Therapeutics plc, and BioPharmX Corp.
SEC CIK
Vivo Capital VIII, LLC's CIK is 0001618789
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Crinetics Pharmaceuticals, Inc. (CRNX) Snapshot price: $50.39
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -4.18% | -330.60K |
$15.37 | -$5,106,752.20 | 7.58M |
Apr 15 - Apr 17
| |||
Form 4
| -5.19% | -306.12K |
$14.00 | -$4,226,833.00 | 5.59M |
Apr 3 - Apr 7
| |||
Form 4
| -0.02% | -528.00 |
$19.50 | -$10,296.00 | 3.27M |
Mar 9
| |||
Form 4
| -0.21% | -13.46K |
$21.70 | -$291,587.00 | 6.54M |
Feb 7 - Feb 10
| |||
Form 4
| -0.41% | -13.46K |
$22.80 | -$306,888.00 | 3.28M |
Feb 4
| |||
Form 4
| -0.27% | -26.92K |
$22.00 | -$594,164.00 | 9.9M |
Jan 29 - Jan 31
| |||
Form 4
| -11.16% | -417.00K |
$22.25 | -$9,278,250.00 | 3.32M |
Mar 20
| |||
Form 4
| +59.34% | 3.74M |
$17.65 | $6,575,421.40 | 10.04M |
Jul 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Menlo Therapeutics Inc. (VYNE) Snapshot price: $1.87
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aligos Therapeutics, Inc. (ALGS) Snapshot price: $14
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.55M |
$15.00 |
—
| 3.55M |
Oct 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Terns Pharmaceuticals, Inc. (TERN) Snapshot price: $7.99
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -6.32% | -420.66K |
$6.65 | -$2,796,859.03 | 6.24M |
Scheduled
|
Apr 1 - Apr 3
| ||
Form 4
| +21.18% | 758.62K |
$7.25 | $5,499,995.00 | 4.34M |
Dec 23
| |||
Form 4
| +20.12% | 600K |
$3.60 | $2,160,000.00 | 3.58M |
Sep 7
| |||
Form 4
| +142.80% | 2.62M |
$2.70 | $6,980,244.40 | 4.46M |
Aug 12 - Aug 16
| |||
Form 4
|
∞
| 2.68M |
$17.00 | $6,075,001.00 | 2.68M |
Feb 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
IMPEL PHARMACEUTICALS INC (IMPL) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -19.93% | -575.00K |
$0.13 | -$74,131.33 | 2.31M |
Dec 15 - Dec 19
| |||
Form 4
| +33.84% | 2.88M |
$14.25 | $9,994,656.00 | 11.41M |
Apr 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||